Tempest Therapeutics Analyst Ratings
Tempest Therapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/11/2023 | 2106.57% | HC Wainwright & Co. | $35 → $47 | Maintains | Buy |
| 08/11/2023 | 1543.19% | HC Wainwright & Co. | → $35 | Reiterates | Buy → Buy |
| 06/05/2023 | 1543.19% | HC Wainwright & Co. | → $35 | Reiterates | Buy → Buy |
| 05/30/2023 | 1543.19% | HC Wainwright & Co. | → $35 | Reiterates | Buy → Buy |
| 05/11/2023 | 1543.19% | HC Wainwright & Co. | → $35 | Reiterates | Buy → Buy |
| 04/28/2023 | 557.28% | Ladenburg Thalmann | $8 → $14 | Maintains | Buy |
| 03/23/2023 | 181.69% | Piper Sandler | $10 → $6 | Maintains | Overweight |
| 03/23/2023 | 1543.19% | HC Wainwright & Co. | → $35 | Reiterates | → Buy |
| 02/08/2023 | 1543.19% | HC Wainwright & Co. | → $35 | Maintains | Buy |
| 09/15/2022 | 275.59% | Ladenburg Thalmann | → $8 | Initiates Coverage On | → Buy |
| 05/16/2022 | 1543.19% | HC Wainwright & Co. | $51 → $35 | Maintains | Buy |
| 10/21/2021 | — | William Blair | Initiates Coverage On | → Outperform | |
| 07/13/2021 | 2294.37% | HC Wainwright & Co. | → $51 | Initiates Coverage On | → Buy |
| 07/06/2021 | 979.81% | Piper Sandler | → $23 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 2023 年 11 月 10 日 | 2106.57% | HC Wainwright & Co. | 35 美元 → 47 美元 | 维护 | 购买 |
| 08/11/2023 | 1543.19% | HC Wainwright & Co. | → 35 美元 | 重申 | 购买 → 购买 |
| 06/05/2023 | 1543.19% | HC Wainwright & Co. | → 35 美元 | 重申 | 购买 → 购买 |
| 05/30/2023 | 1543.19% | HC Wainwright & Co. | → 35 美元 | 重申 | 购买 → 购买 |
| 05/11/2023 | 1543.19% | HC Wainwright & Co. | → 35 美元 | 重申 | 购买 → 购买 |
| 04/28/2023 | 557.28% | 拉登堡塔尔曼 | 8 美元 → 14 美元 | 维护 | 购买 |
| 03/23/2023 | 181.69% | 派珀·桑德勒 | 10 美元 → 6 美元 | 维护 | 超重 |
| 03/23/2023 | 1543.19% | HC Wainwright & Co. | → 35 美元 | 重申 | → 购买 |
| 02/08/2023 | 1543.19% | HC Wainwright & Co. | → 35 美元 | 维护 | 购买 |
| 2022 年 9 月 15 日 | 275.59% | 拉登堡塔尔曼 | → 8 美元 | 启动覆盖范围开启 | → 购买 |
| 05/16/2022 | 1543.19% | HC Wainwright & Co. | 51 美元 → 35 美元 | 维护 | 购买 |
| 2021 年 10 月 21 日 | — | 威廉布莱尔 | 启动覆盖范围开启 | → 跑赢大盘 | |
| 2021 年 7 月 13 日 | 2294.37% | HC Wainwright & Co. | → 51 美元 | 启动覆盖范围开启 | → 购买 |
| 2021 年 6 月 7 日 | 979.81% | 派珀·桑德勒 | → 23 美元 | 启动覆盖范围开启 | → 超重 |
What is the target price for Tempest Therapeutics (TPST)?
Tempest Therapeutics（TPST）的目标价格是多少？
The latest price target for Tempest Therapeutics (NASDAQ: TPST) was reported by HC Wainwright & Co. on October 11, 2023. The analyst firm set a price target for $47.00 expecting TPST to rise to within 12 months (a possible 2106.57% upside). 9 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2023年10月11日公布了Tempest Therapeutics（纳斯达克股票代码：TPST）的最新目标股价。该分析公司将目标股价定为47.00美元，预计TPST将在12个月内升至2106.57％（可能上涨2106.57％）。去年有9家分析公司公布了评级。
What is the most recent analyst rating for Tempest Therapeutics (TPST)?
分析师对Tempest Therapeutics（TPST）的最新评级是多少？
The latest analyst rating for Tempest Therapeutics (NASDAQ: TPST) was provided by HC Wainwright & Co., and Tempest Therapeutics maintained their buy rating.
Tempest Therapeutics（纳斯达克股票代码：TPST）的最新分析师评级由HC Wainwright & Co. 提供，Tempest Therapeutics维持买入评级。
When is the next analyst rating going to be posted or updated for Tempest Therapeutics (TPST)?
Tempest Therapeutics（TPST）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tempest Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tempest Therapeutics was filed on October 11, 2023 so you should expect the next rating to be made available sometime around October 11, 2024.
分析师在进行了广泛的研究后得出了股票评级，包括阅读公开财务报表、与Tempest Therapeutics的高管和客户交谈以及听取财报电话会议。大多数分析师每三个月进行一次评级，因此每家公司每年应获得4个评级。Tempest Therapeutics的最后一次评级是在2023年10月11日提交的，因此你应该预计下一个评级将在2024年10月11日左右公布。
Is the Analyst Rating Tempest Therapeutics (TPST) correct?
分析师对 Tempest Therapeutics (TPST) 的评级正确吗？
While ratings are subjective and will change, the latest Tempest Therapeutics (TPST) rating was a maintained with a price target of $35.00 to $47.00. The current price Tempest Therapeutics (TPST) is trading at is $2.13, which is out of the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的Tempest Therapeutics（TPST）评级保持不变，目标股价为35.00美元至47.00美元。Tempest Therapeutics（TPST）目前的交易价格为2.13美元，超出了分析师的预测区间。